Literature DB >> 17088944

Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.

Xiao-Yong Man1, Xiao-Hong Yang, Sui-Qing Cai, Yong-Gang Yao, Min Zheng.   

Abstract

Vascular endothelial growth factor (VEGF) plays an important role in normal and pathological angiogenesis. VEGF receptors (VEGFRs, including VEGFR-1, VEGFR-2, and VEGFR-3) and neuropilins (NRPs, including NRP-1 and NRP-2) are high-affinity receptors for VEGF and are typically considered to be specific for endothelial cells. Here we showed expression of VEGFRs and NRPs on cultured epidermal keratinocytes at both mRNA and protein levels. We further localized these receptors by immunofluorescence (IF) staining in the epidermis of surgical skin specimens. We found positive staining for VEGFRs and NRPs in all layers of the epidermis except for the stratum corneum. VEGFR-1 and VEGFR-2 are primarily expressed on the cytoplasmic membrane of basal cells and the adjacent spinosum keratinocytes. All layers of the epidermis except for the horny cell layer demonstrated a uniform pattern of VEGFR-3, NRP-1, and NRP-2. Sections staining for NRP-1 and NRP-2 also showed diffuse intense fluorescence and were localized to the cell membrane and cytoplasm of keratinocytes. In another panel of experiments, keratinocytes were treated with different concentrations of VEGF, with or without VEGFR-2 neutralizing antibody in culture. VEGF enhanced the proliferation and migration of keratinocytes, and these effects were partially inhibited by pretreatment with VEGFR-2 neutralizing antibody. Adhesion of keratinocytes to type IV collagen-coated culture plates was decreased by VEGF treatment, but this reduction could be completely reversed by pretreatment with VEGFR-2 neutralizing antibody. Taken together, our results suggest that the expression of VEGFRs and NRPs on keratinocytes may constitute important regulators for its activity and may possibly be responsible for the autocrine signaling in the epidermis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088944      PMCID: PMC1626599          DOI: 10.2119/2006-00024.Man

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  56 in total

Review 1.  Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.

Authors:  Pipsa Saharinen; Tuomas Tammela; Marika J Karkkainen; Kari Alitalo
Journal:  Trends Immunol       Date:  2004-07       Impact factor: 16.687

Review 2.  From the discovery of neuropilin to the determination of its adhesion sites.

Authors:  Hajime Fujisawa
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

3.  Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines.

Authors:  Sylvie Lantuéjoul; Bruno Constantin; Harry Drabkin; Christian Brambilla; Joëlle Roche; Elisabeth Brambilla
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

4.  Expression of Flt-1 and Flk-1 receptors for vascular endothelial growth factor on tumor cells as a new prognostic criterion for locally advanced breast cancer.

Authors:  L G Zhukova; N V Zhukov; M R Lichinitser
Journal:  Bull Exp Biol Med       Date:  2003-05       Impact factor: 0.804

5.  Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development.

Authors:  Chenghua Gu; E Rene Rodriguez; Dorothy V Reimert; Tianzhi Shu; Bernd Fritzsch; Linda J Richards; Alex L Kolodkin; David D Ginty
Journal:  Dev Cell       Date:  2003-07       Impact factor: 12.270

Review 6.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

7.  Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism.

Authors:  Magali Ancelin; Sylvie Chollet-Martin; Marie Astrid Hervé; Chantal Legrand; Jamel El Benna; Martine Perrot-Applanat
Journal:  Lab Invest       Date:  2004-04       Impact factor: 5.662

8.  Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.

Authors:  Oddbjørn Straume; Lars A Akslen
Journal:  Angiogenesis       Date:  2003       Impact factor: 9.596

9.  Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells.

Authors:  K Matsumoto; K Matsumoto; T Nakamura; R H Kramer
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

Review 10.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

View more
  40 in total

1.  VEGFR-2 expression in tumor tissue of breast cancer patients.

Authors:  A A Lushnikova; I B Nasunova; A A Parokonnaya; L N Lyubchenko; E B Kampova-Polevaya
Journal:  Dokl Biol Sci       Date:  2010-10-21

2.  Regulation of adhesion by vascular endothelial growth factor in HaCaT cells.

Authors:  Chunming Li; Xiaoyong Man; Wei Li; Jiong Zhou; Jiaqi Chen; Suiqing Cai; Min Zheng
Journal:  Mol Cell Biochem       Date:  2010-09-28       Impact factor: 3.396

Review 3.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  VEGF upregulates VEGF receptor-2 on human outer root sheath cells and stimulates proliferation through ERK pathway.

Authors:  Wei Li; Zhong-Fa Lu; Xiao-Yong Man; Chun-Ming Li; Jiong Zhou; Jia-Qi Chen; Xiao-Hong Yang; Xian-Jie Wu; Sui-Qing Cai; Min Zheng
Journal:  Mol Biol Rep       Date:  2012-06-16       Impact factor: 2.316

5.  Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis.

Authors:  Helia B Schonthaler; Reto Huggenberger; Stefanie K Wculek; Michael Detmar; Erwin F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

6.  Expression of Angiogenic Factors in Psoriasis Vulgaris.

Authors:  Lakshna Sankar; Dhanalakshmi Arumugam; Sudha Boj; Priyanka Pradeep
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

8.  Impaired nuclear translocation of glucocorticoid receptors: novel findings from psoriatic epidermal keratinocytes.

Authors:  Xiao-Yong Man; Wei Li; Jia-Qi Chen; Jiong Zhou; Lilla Landeck; Kai-Hong Zhang; Zhen Mu; Chun-Ming Li; Sui-Qing Cai; Min Zheng
Journal:  Cell Mol Life Sci       Date:  2013-01-19       Impact factor: 9.261

9.  Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis.

Authors:  Peter M Elias; Jack Arbiser; Barbara E Brown; Heidemarie Rossiter; Mao-Qiang Man; Francesca Cerimele; Debra Crumrine; Roshan Gunathilake; Eung Ho Choi; Yoshikazu Uchida; Erwin Tschachler; Kenneth R Feingold
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

10.  Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor.

Authors:  Cornelia Halin; Hermann Fahrngruber; Josef G Meingassner; Guido Bold; Amanda Littlewood-Evans; Anton Stuetz; Michael Detmar
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.